Showing results (271-280 of 302) with videos related to
Sort By:
Pageof 31
The Oncologist|August 7, 2015
Prognosis and Clinicopathologic Features of Patients With Advanced Stage Isocitrate Dehydrogenase (IDH) Mutant and IDH Wild-Type Intrahepatic CholangiocarcinomaLipika Goyal, Aparna Govindan, Rahul A Sheth, et al.Annals of Surgery|January 20, 2015
Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancerCristina R Ferrone, Giovanni Marchegiani, Theodore S Hong, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 2022
Precision Medicine in Pancreatic Cancer: Patient-Derived Organoid Pharmacotyping Is a Predictive Biomarker of Clinical Treatment ResponseToni T Seppälä, Jacquelyn W Zimmerman, Reecha Suri, et al.Nature Cancer|February 5, 2022
Palbociclib demonstrates intracranial activity in progressive brain metastases harboring cyclin-dependent kinase pathway alterationsPriscilla K Brastianos, Albert E Kim, Nancy Wang, et al.JCO Precision Oncology|July 12, 2021
Circulating Tumor DNA Predicts Pathologic and Clinical Outcomes Following Neoadjuvant Chemoradiation and Surgery for Patients With Locally Advanced Rectal CancerSusan G R McDuff, Karin M Hardiman, Peter J Ulintz, et al.Nature Medicine|January 28, 2004
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancerChristopher G Willett, Yves Boucher, Emmanuelle di Tomaso, et al.JCO Oncology Practice|July 13, 2022
Supportive Oncology Care at Home Intervention for Patients With Pancreatic CancerRyan D Nipp, Eva Gaufberg, Charu Vyas, et al.International Journal of Radiation Oncology, Biology, Physics|May 29, 2014
A phase 1/2 and biomarker study of preoperative short course chemoradiation with proton beam therapy and capecitabine followed by early surgery for resectable pancreatic ductal adenocarcinomaTheodore S Hong, David P Ryan, Darrell R Borger, et al.Annals of Surgery|February 21, 2022
Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) Versus the Standard of Care Imaging in the Diagnosis of Peritoneal CarcinomatosisFelipe S Furtado, Mark Z Wu, Shadi A Esfahani, et al.Journal of the National Cancer Institute|September 28, 2017
Phase II Study of Proton-Based Stereotactic Body Radiation Therapy for Liver Metastases: Importance of Tumor GenotypeTheodore S Hong, Jennifer Y Wo, Darrell R Borger, et al.Pageof 31